Internal Medicine, Hematology & Oncology · Bayside, NY
NPI
1598863458
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
4564 Francis Lewis Blvd Ste 202
Bayside, NY, 11361
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
99,695 services
Medicare patients, 2024
802
Average age 76
Drug cost, 2024
$11.9M
2,563 prescriptions
Company payments, 2025
$27.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Triantafillos J Fillos was code J1439 (injection, ferric carboxymaltose, 1 mg), 32,250 times for 33 patients. In total Triantafillos J Fillos billed 99,695 services in 189 codes, and Medicare paid $1.3M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 32,250 | 33 | $0.86 | $28K |
| 88185 Surgical Pathology Examination | Office | 5,444 | 212 | $22.00 | $120K |
| 36415 Venipuncture Blood Collection | Office | 1,585 | 682 | $8.64 | $14K |
| 85025 Blood Count | Office | 1,527 | 672 | $7.61 | $12K |
| 80053 Clinical Chemistry | Office | 1,291 | 628 | $10.32 | $13K |
| 83615 Clinical Chemistry | Office | 1,120 | 574 | $5.91 | $6,619 |
| 82784 Immunoassay | Office | 1,101 | 255 | $9.04 | $9,952 |
| 99214 Office E&M - Established | Office | 849 | 456 | $104.01 | $88K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 804 | 42 | $0.09 | $72.22 |
| 83521 Immunoassay | Office | 740 | 256 | $16.83 | $12K |
| 84550 Clinical Chemistry | Office | 718 | 441 | $4.41 | $3,167 |
| 82728 Clinical Chemistry | Office | 656 | 403 | $13.30 | $8,724 |
| 83540 Clinical Chemistry | Office | 653 | 403 | $6.31 | $4,123 |
| 83550 Clinical Chemistry | Office | 642 | 396 | $8.54 | $5,485 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 556 | 124 | $51.34 | $29K |
By year: 2022 $2.2M for 223,377 services; 2023 $1.2M for 120,775 services; 2024 $1.3M for 99,695 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 5,444 | 212 | $22.00 | $120K |
| 36415 Venipuncture Blood Collection | 1,585 | 682 | $8.64 | $14K |
| 85025 Blood Count | 1,527 | 672 | $7.61 | $12K |
| 80053 Clinical Chemistry | 1,291 | 628 | $10.32 | $13K |
| 83615 Clinical Chemistry | 1,120 | 574 | $5.91 | $6,619 |
| 82784 Immunoassay | 1,101 | 255 | $9.04 | $9,952 |
| 83521 Immunoassay | 740 | 256 | $16.83 | $12K |
| 84550 Clinical Chemistry | 718 | 441 | $4.41 | $3,167 |
| 82728 Clinical Chemistry | 656 | 403 | $13.30 | $8,724 |
| 83540 Clinical Chemistry | 653 | 403 | $6.31 | $4,123 |
Medicare prescription drug claims, 2024
In 2024, the drug Triantafillos J Fillos prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 236 prescriptions and refills. In total Triantafillos J Fillos wrote 2,563 Medicare prescriptions that cost $11.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 236 | 243 | 61 | $591K |
| Anastrozole Generic | 207 | 423 | 64 | $3,438 |
| Akynzeo Fosnetupitant/Palonosetron | 128 | 128 | 34 | $134K |
| Hydroxyurea Generic | 111 | 163 | 24 | $1,209 |
| Procrit Epoetin Alfa | 69 | 69 | 13 | $126K |
| Eliquis Apixaban | 61 | 91 | 24 | $51K |
| Ondansetron Odt Ondansetron | 55 | 55 | 36 | $705 |
| Xgeva Denosumab | 54 | 69 | 14 | $167K |
| Imatinib Mesylate Generic | 51 | 51 | Under 11 | $84K |
| Revlimid Lenalidomide | 49 | 49 | Under 11 | $832K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 43 | 43 | Under 11 | $651K |
| Prednisone Generic | 42 | 52 | 12 | $351 |
| Pomalyst Pomalidomide | 39 | 39 | Under 11 | $902K |
| Brukinsa Zanubrutinib | 39 | 39 | Under 11 | $526K |
| Acyclovir Generic | 35 | 35 | Under 11 | $153 |
Brand drugs: 1,384 claims; generic drugs: 1,179 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Triantafillos J Fillos $27.36 ($27.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Menarini Silicon Biosystems, Inc. with $27.36.
| Company | Payments | Amount |
|---|---|---|
| Menarini Silicon Biosystems, Inc. | 1 | $27.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.